October 13, 2021
Oct. 13, 2021 /PRNewswire/ — FLG Client Lark Health today announced that it has closed a $100 million Series D funding round led by Deerfield Management Company. The funding round also includes crossover fund PFM Health Sciences, as well as returning investors Franklin Templeton, King River Capital, Castlepeak, IPD, Olive Tree Capital, and Marvell Technology cofounder Weili Dai. Funding will support further research and development for Lark’s AI Chronic Disease Management Platform and help expand the company’s virtual care integrations. FLG’s Bill Beyer assisted with the financing.
Full press release is here.